Please login to the form below

Not currently logged in
Email:
Password:

Richard Chin joins board of ImmunoCellular Therapeutics

Adds drug development experience as company looks to advance brain tumour vaccine

Former CEO of the non-profit pharma firm OneWorld Health Dr Richard Chin has joined the board of directors at ImmunoCellular Thereapeutics.

Chin, who currently serves on the adjunct faculty of the University of California, San Francisco School of Medicine, will also become chair of the compensation committee at ImmunoCellular – a US-based clinical-stage company developing immune-based therapies for the treatment of cancer.

“His extensive experience in drug development will be valuable as the company advances its phase II clinical trial of ICT-107,” said ImmunoCellular's chairman Dr John Yu, referencing the company's cancer vaccine currently in development for the brain tumour glioblastoma multiforme.

Chin spent left OneWorld Health in 2011 after spending three years leading the organisation, which aims to develop new treatments for neglected diseases. It is largely funded by the Bill and Melinda Gates Foundation.

Prior to this role, he was president and CEO of biopharma Oxigene from 2006 to 2008 and he has also held senior roles at Elan and Genentech.

19th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics